ARCHIVES

ImClone: Waksals To Pay $5 Million To Settle With SEC.

This article is from The Cancer Letter archive.

Vol. 31 No. 04 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

Stem Cell Transplant More Effective than Chemotherapy

April 25, 2003

Reinventing NCI: Clinical Trials System Changes Not Easy Or Quick, Klausner Says; NCAB Members, Others, Sound Off On Group’s Report

October 10, 1997

Randomized Trials Discovered Roles For Newly Approved Nexavar and Sutent.

February 24, 2006

Gleevec Approval Sets Record For FDA Review: 73 Days

May 25, 2001

NCCS Networker Volume 5 Issue 1, Winter 1991

January 13, 1991

Support Available For Studies Abroad

August 12, 1983